-
DNA–RNA Methylation Drives EGFR-TKI Resistance
2026-09-22
The reference study identifies a coordinated DNA 5-methylcytosine and RNA m5C mechanism that shifts MZF1 splicing toward the zinc-binding-deficient MZF1S isoform in EGFR-TKI-resistant NSCLC. Its findings connect UHRF1/DNMT1, NSUN7/YBX1, and SRSF1/SRSF3 activity to therapeutic resensitization, while suggesting methylation-regulated splice variants as biomarkers and intervention points.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-22
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer-cell proliferation, and metabolism. This guide supports preclinical assay planning and compound handling, but the reagent should not be used to infer clinical efficacy or substituted into protocols that require aqueous solubility.
-
Structure-Based Screening of SARS-CoV-2 NSP15 Inhibitors
2026-09-21
The reference study used structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as high-priority ligands for the SARS-CoV-2 NSP15 endoribonuclease. Its main contribution is a computational framework for targeting viral immune-evasion machinery, while its predictions still require biochemical, cellular, and virological validation.
-
VX-661 and the Proteostasis Logic of CFTR Rescue
2026-09-21
A translational analysis of VX-661 as an F508del CFTR corrector, connecting CFTR folding, calnexin-dependent proteostasis, experimental design, combination strategy, and precision cystic fibrosis research.
-
Pazopanib (GW-786034) in RTK Cancer Models
2026-09-20
Pazopanib (GW-786034) enables mechanism-first studies of VEGF, PDGF, and FGF receptor signaling across endothelial, tumor, and ATRX-stratified glioma models. This workflow combines target-engagement assays with phenotype, combination, and troubleshooting guidance for more reproducible cancer research.
-
Mestranol Drives Reversible Lysosomal Stress in Microglia
2026-09-19
A 2026 Aquatic Toxicology study identifies mestranol as an inducer of a reversible lysosomal storage–like state in zebrafish microglia. The work separates preserved phagocytic uptake from defective intracellular digestion and combines live imaging, functional assays, transcriptomics, and TFEC rescue to model environmental estrogen-associated neuroimmunotoxicity.
-
Ertapenem Sodium Salt in Carbapenem Resistance Research
2026-09-18
A translational framework for using Ertapenem sodium salt to connect penicillin-binding protein biology, carbapenemase mobility, susceptibility testing, pharmacokinetic context, and resistance surveillance.
-
Puromycin aminonucleoside: Podocyte Workflows
2026-09-18
Build reproducible podocyte injury, proteinuria, and glomerular lesion workflows with a reagent that connects cellular morphology to whole-animal renal pathology. This guide emphasizes assay design, pH- and transporter-aware optimization, storage, and troubleshooting for nephrotic syndrome research.
-
Phillygenin in Diabetic Nephropathy: Mechanisms and Evidence
2026-09-17
The reference study identifies phillygenin as a potential intervention for diabetic nephropathy by connecting reduced inflammation and apoptosis with coordinated regulation of TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. Its combination of high-glucose podocyte experiments, RNA sequencing, and db/db mouse validation provides a mechanistic foundation while leaving important questions about causality and clinical translation.
-
Lactylation–NSUN2 Drives PDAC Perineural Invasion
2026-09-17
This study identifies NSUN2 K692 lactylation as a metabolic mechanism linking lactate accumulation to m5C-dependent stabilization of CDCP1 and STC1 transcripts in pancreatic ductal adenocarcinoma. Integrated cellular, molecular, neural co-culture, and mouse-model experiments show that the lactate–NSUN2–m5C axis promotes tumor–nerve interactions and perineural invasion, providing a mechanistic framework for future therapeutic investigation.
-
WY-14643 (Pirinixic Acid): Reliable Assays
2026-09-16
A scenario-driven guide to using WY-14643 (Pirinixic Acid), SKU A4305, in cell viability, proliferation, inflammation, and metabolic disorder research. It covers solvent handling, dose design, assay compatibility, interpretation, and practical vendor-selection criteria.
-
Triamcinolone: Practical Assay Workflow Guide
2026-09-16
Triamcinolone (B1859) provides a defined synthetic glucocorticoid agonist for controlled studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide covers DMSO-based preparation, storage, controls, and assay qualification; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical purposes.
-
Magneto-Piezoelectric Scaffolds for Infected Bone Repair
2026-09-15
This ACS Nano study combines magneto-piezoelectric nanoparticles, engineered cell membranes, and 3D-printed scaffolds to address both biofilm infection and impaired bone regeneration. Its central mechanistic finding is that sequential magnetic and ultrasound stimulation disrupts biofilms while activating oxidative phosphorylation through JAK2-STAT3 signaling in Icam1+ macrophages.
-
Difloxacin HCl Workflows for Resistance Research
2026-09-15
Difloxacin HCl supports two distinct research workflows: organism-level antimicrobial susceptibility testing and exploratory MRP substrate sensitization in resistant neuroblastoma models. This guide connects formulation, assay controls, troubleshooting, and the mechanistic insights of a mitotic checkpoint study without treating antibacterial or cell-cycle evidence as interchangeable.
-
VX-765 Workflow for Caspase-1 and Pyroptosis
2026-09-14
Build cleaner inflammasome experiments with VX-765 by separating caspase-1-dependent cytokine release from nonspecific cytotoxicity. This workflow covers formulation, timing, cytokine and pyroptosis readouts, and the limitations revealed by recent IL-1β cleavage research.